 - Has any concurrent disease andor medical condition that, in the opinion of the Investigator, would prevent the subjects participation, render the subject at excessive risk including excessive risks due to the toxicity profile of the planned combination chemotherapeutic regimen, or limit the subjects compliance with the protocols required evaluations. 